HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis

Growth Factors

Volumn 26, Issue 6, 2008, Pages 301-315

  Mehta, Veela B ^a   Zhou, Yu ^a   Radulescu, Andrei ^a   Besner, Gail ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Angiogenesis; eNOS; Matrigel plug assay; HB EGF; p38 MAPK

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; N(G) NITROARGININE METHYL ESTER; PHOSPHATIDYLINOSITOL 3 KINASE; SMALL INTERFERING RNA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL MIGRATION; CELL STIMULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ASSAY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UMBILICAL VEIN; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 57249114643     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.1080/08977190802393596     Document Type: Article

References (90)

1. Abraham, JA, Damm, D., Bajardi, A., Miller, J., Klagsbrun, M. and Ezekowitz, RA (1993) Heparin-binding EGF-like growth factor: Characterization of rat and mouse cDNA clones, protein domain conservation across species, and transcript expression in tissues. Biochem Biophys Res Commun, 190, pp. 125-133.
2. Adam, RM, Kim, J., Lin, J., Orsola, A., Zhuang, L., Rice, DC and Freeman, MR (2002) Heparin-binding epidermal growth factor-like growth factor stimulates androgen-independent prostate tumor growth and antagonizes androgen receptor function. Endocrinology, 143, pp. 4599-4608.
3. Aviezer, D. and Yayon, A. (1994) Heparin-dependent binding and autophosphorylation of epidermal growth factor (EGF) receptor by heparin-binding EGF-like growth factor but not by EGF. Proc Natl Acad Sci USA, 91, pp. 12173-12177.
4. Besner, G., Higashiyama, S. and Klagsbrun, M. (1990) Isolation and characterization of a macrophage-derived heparin-binding growth factor. Cell Regul, 1, pp. 811-819.
5. Bossaller, C., Habib, GB, Yamamoto, H., Williams, C., Wells, S. and Henry, PD (1987) Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5'-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest, 79, pp. 170-174.
6. Chen J, Somanath PR, Razorenova O, Chen WS, Hay N, Bornstein P and Byzova TV (2005) Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nat Med, 11, pp. 1188-1196.
7. Cho, H., Thorvaldsen, JL, Chu, Q., Feng, F. and Birnbaum, MJ (2001) Akt1/ PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem, 276, pp. 38349-38352.
8. Cribbs, RK, Luquette, MH and Besner, GE (1998) Acceleration of partial-thickness burn wound healing with topical application of heparin-binding EGF-like growth factor (HB-EGF). J Burn Care Rehabil, 19, pp. 95-101.
9. D'Amore, PATR (1987) Mechanisms of angiogenesis. Annu Rev Physiol, 49, pp. 453-464.
10. Das, SK, Wang, X-N, Paria, BC, Damm, D., Abraham, JA, Klagsbrun, M., Andrews, GK and Dey, SK (1994) Heparin-binding EGF-like growth factor gene is induced in the mouse uterus temporally by the blastocyst solely at the site of its apposition: A possible ligand for interaction with blastocyst EGF-receptor in implantation. Development, 120, pp. 1071-1083.
11. Davis, KM, Brigstock, DR, Johnson, PR, Crissman-Combs, MA, McCarthy, DW, Downing, MT and Besner, GE (1996) Production of glycosylated heparin-binding EGF-like growth factor in HeLa cells using vaccinia virus. Protein Expr Purif, 8, pp. 57-67.
12. Dluz, SM, Higashiyama, S., Damm, D., Abraham, JA and Klagsbrun, M. (1993) Heparin-binding epidermal growth factor-like growth factor expression in cultured fetal human vascular smooth muscle cells. Induction of mRNA levels and secretion of active mitogen. J Biol Chem, 268, pp. 18330-18334.
13. El-Assal, ON and Besner, GE (2005) HB-EGF enhances restitution after intestinal ischemia/reperfusion via PI3K/Akt and MEK/ERK1/2 activation. Gastroenterology, 129, pp. 609-625.
14. Elenius, K., Corfas, G., Paul, S., Choi, CJ, Rio, C., Plowman, GD and Klagsbrun, M. (1997) A novel juxtamembrane domain isoform of HER4/ErbB4. Isoform-specific tissue distribution and differential processing in response to phorbol ester. J Biol Chem, 272, pp. 26761-26768.
15. Elenius, K., Paul, S., Allison, G., Sun, J. and Klagsbrun, M. (1997) Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J, 16, pp. 1268-1278.
16. Ellis, PD, Hadfield, KM, Pascall, JC and Brown, KD (2001) Heparin-binding epidermal-growth-factor-like growth factor gene expression is induced by scrape-wounding epithelial cell monolayers: Involvement of mitogen-activated protein kinase cascades. Biochem J, 354, pp. 99-106.
17. Ester Wja Albrecht CASPHRHHHvG (2003) Protective role of endothelial nitric oxide synthase. J Pathol, 199, pp. 8-17.
18. Fang, L., Li, G., Liu, G., Lee, SW and Aaronson, SA (1939) p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades. EMBO J, 20, pp. 1931-1939.
19. Ferrara, N. and Gerber, H-P (2001) The role of vascular endothelial growth factor in angiogenesis. Acta Haematol, 106, pp. 148-156.
20. Fischer, OM, Hart, S., Gschwind, A. and Ullrich, A. (2003) EGFR signal transactivation in cancer cells. Biochem Soc Trans, 31, pp. 1203-1208.
21. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med, 1, pp. 27-31.
22. Freedman, JE, Sauter, R., Battinelli, EM, Ault, K., Knowles, C., Huang, PL and Loscalzo, J. (1999) Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOSIII gene. Circ Res, 84, pp. 1416-1421.
23. Fukumura, D., Gohongi, T., Kadambi, A., Izumi, Y., Ang, J., Yun, C-O, Buerk, DG, Huang, PL and Jain, RK (2001) Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA, 98, pp. 2604-2609.
24. Fulton, D., Gratton, J-P, McCabe, TJ, Fontana, J., Fujio, Y., Walsh, K., Franke, TF, Papapetropoulos, A. and Sessa, WC (1999) Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature, 399, p. 597.
25. Fulton, D., Church, JE, Ruan, L., Li, C., Sood, SG, Kemp, BE, Jennings, IG and Venema, RC (2005) Src kinase activates endothelial nitric-oxide synthase by phosphorylating Tyr-83. J Biol Chem, 280, pp. 35943-35952.
26. Fu, S-I, Bottoli, I., Goller, M. and Vogt, PK (1999) Heparin-binding epidermal growth factor-like growth factor, a v-Jun target gene, induces oncogenic transformation. Proc Natl Acad Sci USA, 96, pp. 5716-5721.
27. Garcia-Cardena, G., Fan, R., Shah, V., Sorrentino, R., Cirino, G., Papapetropoulos, A. and Sessa, WC (1998) Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature, 392, pp. 821-824.
28. Gerber, H-P, McMurtrey, A., Kowalski, J., Yan, M., Keyt, BA, Dixit, V. and Ferrara, N. (1998) Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/ KDR activation. J Biol Chem, 273, pp. 30336-30343.
29. Goishi, K., Higashiyama, S., Klagsbrun, M., Nakano, N., Umata, T., Ishikawa, M., Mekada, E. and Taniguchi, N. (1995) Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: Conversion from juxtacrine to paracrine growth factor activity. Mol Biol Cell, 6, pp. 967-980.
30. He, H., Venema, VJ, Gu, X., Venema, RC, Marrero, MB and Caldwell, RB (1999) Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through Flk-1/KDR activation of c-Src. J Biol Chem, 274, pp. 25130-25135.
31. Higashiyama, S., Abraham, J., Catalano, R. and Klagsbrun, M. (1991) Heparin-binding EGF-like growth factor (HB-EGF) is produced by cultured smooth muscle cells. J Cell Biol, 115, p. A73.
32. Higashiyama, S., Abraham, JA, Miller, J., Fiddes, JC and Klagsbrun, M. (1991) A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science, 251, pp. 936-939.
33. Higashiyama, S., Lau, K., Besner, GE, Abraham, JA and Klagsbrun, M. (1992) Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein. J Biol Chem, 267, pp. 6205-6212.
34. Higashiyama, S., Abraham, JA and Klagsbrun, M. (1994) Heparin-binding EGF-like growth factor synthesis by smooth muscle cells. Horm Res, 42, pp. 9-13.
35. Homma, MS, Cheng, F., Yasuda, T., Coffey Jr, RJ and Harris, RC (1995) Induction of heparin-binding epidermal growth factor-like growth factor mRNA in rat kidney after acute injury. J Clin Invest, 96, pp. 1018-1025.
36. Hood, JD, Meininger, CJ, Ziche, M. and Granger, HJ (1998) VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol Heart Circ Physiol, 274, pp. H1054-H1058.
37. Isner, JM and Losordo, DW (1999) Therapeutic angiogenesis for heart failure. Nat Med, 5, pp. 491-492.
38. Iwamoto, R. and Mekada, E. (2000) Heparin-binding EGF-like growth factor: A juxtacrine growth factor. Cytokine Growth Factor Rev, 11, pp. 335-344.
39. Iwamoto, R., Yamazaki, S., Asakura, M., Takashima, S., Hasuwa, H., Miyado, K., Adachi, S., Kitakaze, M., Hashimoto, K., Raab, G., Nanba, D., Higashiyama, S., Hori, M., Klagsbrun, M. and Mekada, E. (2003) Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc Natl Acad Sci USA, 100, pp. 3221-3226.
40. Jackson, LF, Qiu, TH, Sunnarborg, SW, Chang, A., Zhang, C., Patterson, C. and Lee, DC (2003) Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J, 22, pp. 2704-2716.
41. Jin, K., Mao, XO, Sun, Y., Xie, L., Jin, L., Nishi, E., Klagsbrun, M. and Greenberg, DA (2002) Heparin-binding epidermal growth factor-like growth factor: Hypoxia-inducible expression in vitro and stimulation of neurogenesis in vitro and in vivo. J Neurosci, 22, pp. 5365-5373.
42. Klagsbrun, M. and D'Amore, PA (1991) Regulators of angiogenesis. Annu Rev Physiol, 53, pp. 217-239.
43. Kroll, J. and Waltenberger, J. (1998) VEGF-a induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem Biophys Res Commun, 252, pp. 743-746.
44. Lauffenburger, DA and Horwitz, AF (1996) Cell migration: A physically integrated molecular process. Cell, 84, pp. 359-369.
45. Le Cras, RCT, Horan, Morris, KG, Tuder, RM, McMurtry, IF, Johns, RA and Abman, SH (1998) Effects of chronic hypoxia and altered hemodynamics on endothelial nitric oxide synthase expression in the adult rat lung. J Clin Invest, 101, pp. 795-801.
46. Lee, PC, Salyapongse, AN, Bragdon, GA, Shears II, LL, Watkins, SC, Edington, HDJ and Billiar, TR (1999) Impaired wound healing and angiogenesis in eNOS-deficient mice. Am J Physiol Heart Circ Physiol, 277, pp. H1600-H1608.
47. Liekens, S., De Clercq, E. and Neyts, J. (2001) Angiogenesis: Regulators and clinical applications. Biochem Pharmacol, 61, pp. 253-270.
48. Madri, JA, Pratt, BM and Tucker, AM (1988) Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix. J Cell Biol, 106, pp. 1375-1384.
49. Mary, M. and Kavurma, LMK (2003) ERK, JNK, and p38 MAP kinases differentially regulate proliferation and migration of phenotypically distinct smooth muscle cell subtypes. J Cell Biochem, 89, pp. 289-300.
50. Matsumoto, S., Kishida, K., Shimomura, I., Maeda, N., Nagaretani, H., Matsuda, M., Nishizawa, H., Kihara, S., Funahashi, T. and Matsuzawa, Y. (2002) Increased plasma HB-EGF associated with obesity and coronary artery disease. Biochem Biophys Res Commun, 292, pp. 781-786.
51. Mehta, VB and Besner, GE (2003) Inhibition of NF-kappa B activation and its target genes by heparin-binding epidermal growth factor like growth factor. J Immunol, 171, pp. 6014-6022.
52. Mehta, VB and Besner, GE (2007) HB-EGF promotes angiogenesis in endothelial cells via PI3-kinase and MAPK signaling pathways. Growth Factors, 25, pp. 253-263.
53. Michalsky, M., Kuhn, A., Mehta, V. and Besner, GE (2001) Heparin-binding EGF-like growth factor (HB-EGF) decreases apoptosis in intestinal epithelial cells in vitro. J Pediatr Surg, 36, pp. 1130-1135.
54. Mitchison, TJ and Cramer, LP (1996) Actin-based cell motility and cell locomotion. Cell, 84, pp. 371-379.
55. Morales-Ruiz, M., Fulton, D., Sowa, G., Languino, LR, Fujio, Y., Walsh, K. and Sessa, WC (2000) Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase akt. Circ Res, 86, pp. 892-896.
56. Morimoto, C. and Higashiyama, S. (2005) Heparin-binding EGF-like growth factor (HB-EGF). Nippon Rinsho, 63:8, pp. 110-112.
57. Murohara, T., Asahara, T., Silver, M., Bauters, C., Masuda, H., Kalka, C., Kearney, M., Chen, D., Symes, JF, Fishman, MC, Huang, PL and Isner, JM (1998) Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest, 101, pp. 2567-2578.
58. Nadaud, S., Philippe, M., Arnal, J-F, Michel, J-B and Soubrier, F. (1996) Sustained increase in aortic endothelial nitric oxide synthase expression in vivo in a model of chronic high blood flow. Circ Res, 79, pp. 857-863.
59. Naglich, JG, Metherall, JE, Russell, DW and Eidels, L. (1992) Expression cloning of a diphtheria toxin receptor: Identity with a heparin-binding EGF-like growth factor precursor. Cell, 69, pp. 1051-1061.
60. Nathan, C. and Xie, QW (1994) Nitric oxide synthases: Roles, tolls, and controls. Cell, 78, pp. 915-918.
61. Nathan, C. and Xie, QW (1994) Regulation of biosynthesis of nitric oxide. J Biol Chem, 269, pp. 13725-13728.
62. Nishi, E. and Klagsbrun, M. (2004) Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a mediator of multiple physiological and pathological pathways. Growth Factors, 22, pp. 253-260.
63. Nishi, E., Prat, A., Hospital, V., Elenius, K. and Klagsbrun, M. (2001) N-Arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration. EMBO J, 20, pp. 3342-3350.
64. Ongusaha, PP, Kwak, JC, Zwible, AJ, Macip, S., Higashiyama, S., Taniguchi, N., Fang, L. and Lee, SW (2004) HB-EGF is a potent inducer of tumor growth and angiogenesis. Cancer Res, 64, pp. 5283-5290.
65. Papapetropoulos, A., Garcia-Cardena, G., Madri, JA and Sessa, WC (1997) Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest, 100, pp. 3131-3139.
66. Passaniti, ATR, Pili, R., Guo, Y., Long, PV, Haney, JA, Pauly, RR, Grant, DS and Martin, GR (1992) A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest, 67, pp. 519-528.
67. Pillai, SB, Hinman, CE, Luquette, MH, Nowicki, PT and Besner, GE (1999) Heparin-binding epidermal growth factor-like growth factor protects rat intestine from ischemia/reperfusion injury. J Surg Res, 87, pp. 225-231.
68. Quinlan, TR, Li, D., Laubach, VE, Shesely, EG, Zhou, N. and Johns, RA (2000) eNOS-deficient mice show reduced pulmonary vascular proliferation and remodeling to chronic hypoxia. Am J Physiol Lung Cell Mol Physiol, 279, pp. L641-L650.
69. Raab, G. and Klagsbrun, M. (1997) Heparin-binding EGF-like growth factor. Biochim Biophys Acta, 1333, p. F179.
70. Re, RN and Cook, JL (2007) Potential therapeutic implications of intracrine angiogenesis. Med Hypotheses, 69, pp. 414-421.
71. Rousseau, S., Houle, F., Kotanides, H., Witte, L., Waltenberger, J., Landry, J. and Huot, J. (2000) Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase. J Biol Chem, 275, pp. 10661-10672.
72. Rudi Busse, IF (1998) Regulation of NO synthesis in endothelial cells. Kidney Blood Press Res, 21, pp. 264-266.
73. Rudic, RD, Shesely, EG, Maeda, N., Smithies, O., Segal, SS and Sessa, WC (1998) Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest, 101, pp. 731-736.
74. Sankar, S., Mahooti-Brooks, N., Bensen, L., McCarthy, TL, Centrella, M. and Madri, JA (1996) Modulation of transforming growth factor beta receptor levels on microvascular endothelial cells during in vitro angiogenesis. J Clin Invest, 97, pp. 1436-1446.
75. Sessa, WC (2004) eNOS at a glance. J Cell Sci, 117, pp. 2427-2429.
76. Sharma, G-D, He, J. and Bazan, HEP (1997) 2003. p38 and ERK1/2 coordinate cellular migration and proliferation in epithelial wound healing: Evidence of cross-talk activation between map kinase cascades. J Biol Chem, 278, pp. 21982-21989.
77. Shirakata, Y., Kimura, R., Nanba, D., Iwamoto, R., Tokumaru, S., Morimoto, C., Yokota, K., Nakamura, M., Sayama, K., Mekada, E., Higashiyama, S. and Hashimoto, K. (2005) Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing. J Cell Sci, 118, pp. 2363-2370.
78. Sugiura, S., Kitagawa, K., Tanaka, S., Todo, K., Omura-Matsuoka, E., Sasaki, T., Mabuchi, T., Matsushita, K., Yagita, Y. and Hori, M. (2005) Adenovirus-mediated gene transfer of heparin-binding epidermal growth factor-like growth factor enhances neurogenesis and angiogenesis after focal cerebral ischemia in rats. Stroke, 36, pp. 859-864.
79. Tai, SC, Robb, GB and Marsden, PA (2004) Endothelial nitric oxide synthase: A new paradigm for gene regulation in the injured blood vessel. Arterioscler Thromb Vasc Biol, 24, pp. 405-412.
80. Takemura, T., Kondo, S., Homma, T., Sakai, M. and Harris, RC (1997) The membrane-bound form of heparin-binding epidermal growth factor-like growth factor promotes survival of cultured renal epithelial cells. J Biol Chem, 272, pp. 31036-31042.
81. Takemura, T., Hino, S., Kuwajima, H., Yanagida, H., Okada, M., Nagata, M., Sasaki, SEI, Barasch, J., Harris, RC and Yoshioka, K. (2001) Induction of collecting duct morphogenesis in vitro by heparin-binding epidermal growth factor-like growth factor. J Am Soc Nephrol, 12, pp. 964-972.
82. Tanimoto, T., Jin, Z-G and Berk, BC (2002) Transactivation of vascular endothelial growth factor (VEGF) receptor Flk-1/KDR is involved in sphingosine 1-phosphate-stimulated phosphorylation of Akt and endothelial nitric-oxide synthase (eNOS). J Biol Chem, 277, pp. 42997-43001.
83. Tokumaru, S., Higashiyama, S., Endo, T., Nakagawa, T., Miyagawa, J., Yamamori, K., Hanakawa, Y., Ohmoto, H., Yoshino, K., Shirakata, Y., Matsuzawa, Y., Hashimoto, K. and Taniguchi, N. (2000) Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. J Cell Biol, 151, pp. 209-220.
84. Wang, Q. and Doerschuk, CM (2001) The p38 mitogen-activated protein kinase mediates cytoskeletal remodeling in pulmonary microvascular endothelial cells upon intracellular adhesion molecule-1 ligation. J Immunol, 166, pp. 6877-6884.
85. Webb, DJ, Donais, K., Whitmore, LA, Thomas, SM, Turner, CE, Parsons, JT and Horwitz, AF (2004) FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol, 6, pp. 154-161.
86. Weuste, M., Wurm, A., Iandiev, I., Wiedemann, P., Reichenbach, A. and Bringmann, A. (2006) HB-EGF: Increase in the ischemic rat retina and inhibition of osmotic glial cell swelling. Biochem Biophys Res Commun, 347, pp. 310-318.
87. Wilcox, JN, Subramanian, RR, Sundell, CL, Tracey, WR, Pollock, JS, Harrison, DG and Marsden, PA (1997) Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Biol, 17, pp. 2479-2488.
88. Yu, J., Bian, D., Mahanivong, C., Cheng, RK, Zhou, W. and Huang, S. (2004) p38 Mitogen-activated protein kinase regulation of endothelial cell migration depends on urokinase plasminogen activator expression. J Biol Chem, 279, pp. 50446-50454.
89. Zachary, I. (2003) VEGF signalling: Integration and multi-tasking in endothelial cell biology. Biochem Soc Trans, 31, pp. 1171-1177.
90. Ziche, M. and Morbidelli, L. (2000) Nitric oxide and angiogenesis. J Neuro-Oncol, 50, pp. 139-148.